Propacetamol hydrochloride,
66532-86-3,
Propacetamol HCL,
4-Acetamidophenyl 2-(diethylamino)acetate hydrochloride,
UNII-SH41QYH8E5,
SH41QYH8E5,
4-Acetamidophenyl N,N-diethylaminoacetate monohydrochloride,
Pro-Dafalgan,
(4-acetamidophenyl) 2-(diethylamino)acetate hydrochloride,
Pro-efferalgan,
Glycine, N,N-diethyl-, 4-(acetylamino)phenyl ester, monohydrochloride,
EINECS 266-391-7,
Pro-dafalgan (TN),
Propacetamol HCl Sterile,
propacetamol-hydrochloride,
4-acetamidophenyl n,n-diethylglycinate hydrochloride,
AC1L33B5,
AC1Q619A,
CHEMBL1795480,
DTXSID60216721,
WGTYJNGARJPYKG-UHFFFAOYSA-N,
N,N-diethylglycine 4-(acetylamino)phenyl ester hydrochloride,
BCP21307,
KM1018,
MFCD00941392,
AKOS015888645,
AC-4240,
ACN-048527,
VA11596,
AK128961,
AN-12159,
AS-14148,
BC683951,
K088,
UP-34101,
AX8149161,
Propacetamol hydrochloride, >=98% (HPLC),
TL8004709,
FT-0655178,
4-Acetamidophenyl 2-(Diethylamino)Acetate HCl,
D08434,
532P852,
C-23874,
p-acetamidophenyl diethylaminoacetate hydrochloride,
I01-1210,
Propacetamol,
C14H21ClN2O3,
C14H20N2O3.ClH,
C14-H20-N2-O3.Cl-H,
AR-1G0336,
CID108082,
4-Acetamidophenyl2-(diethylamino)acetatehydrochloride,
66532-85-2,
6812-87-9,